Abstract:Background Enhancer RNAs (eRNAs) are intergenic long non-coding RNAs (lncRNAs) that participate in the progression of malignancies by targeting tumor-related genes and immune checkpoints. However, the potential role of eRNAs in hepatocellular carcinoma (HCC) is unclear. In this study, we aimed to construct an immune-related eRNA prognostic model that could be used to prospectively assess the prognosis of patients with HCC. Methods Gene expression profiles of patients with HCC were downloaded from The Cancer Genome Atlas (TCGA). The eRNAs co-expressed from immune genes were identified as immune-related eRNAs. Cox regression analyses were applied in a training cohort to construct an immune-related eRNA signature (IReRS), that was subsequently used to analyze a testing cohort and combination of the two cohorts. Kaplan-Meier and receiver operating characteristic (ROC) curves were used to validate the predictive effect in the three cohorts. Gene Set Enrishment Analysis (GSEA) computation was used to identify an IReRS-related signaling pathway. A web-based cell type identification by estimating relative subsets of RNA transcripts (CIBERSORT) computation was used to evaluate the relationship between the IReRS and infiltrating immune cells. Results A total of sixty-four immune-related eRNAs (IReRNAs) was identified in HCC, and 14 IReRNAs were associated with overall survival (OS). Five IReRNAs were used for constructing an immune-related eRNA signature (IReRS), which was shown to correlate with poor survival and to be an independent prognostic biomarker for HCC. The GSEA results showed that the IReRS was correlated to cancer-related and immune-related pathways. Moreover, we found that IReRS was correlated to infiltrating immune cells, including CD8 + T cells and M0 macrophages. Finally, differential expressions of the five risk IReRNAs in tumor tissues vs. adjacent normal tissues and their prognostic values were verified, in which the AL445524.1 may function as an oncogene that affects prognosis partly by regulating CD4-CLTA4 related genes. Conclusion Our results suggest that the IReRS could serve as a biomarker for predicting prognosis in patients with HCC. Additionally, it may be correlated to the tumor immune microenvironment and could also be used as a biomarker in immunotherapy for HCC.

Identification of Prognosis- and Metastasis-related Enhancer RNAs in Renal Cell Carcinoma

Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer

Comprehensive Transcriptomic Analysis of Critical RNA Regulation Associated With Metabolism and Prognosis in Clear Cell Renal Carcinoma

Identification Of Rna Transcript Makers Associated With Prognosis Of Kidney Renal Clear Cell Carcinoma By A Competing Endogenous Rna Network Analysis

Screening and Identification of Novel Promoter Signatures in Clear Cell Renal Cell Carcinoma Metastasis.

Identification of Six Potentially Long Noncoding RNAs As Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma

Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma

Weighted Gene Co-Expression Network Analysis to Construct Competitive Endogenous RNAs Network in Chromogenic Renal Cell Carcinoma

Identification of Novel Enhancer RNA Biomarkers and Corresponding Prognostic Signatures of Hepatocellular Carcinoma

An optimal prognostic model based on gene expression for clear cell renal cell carcinoma

A Novel Mrna-Mirna Regulatory Sub-Network Associated with Prognosis of Metastatic Clear Cell Renal Cell Carcinoma.

MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma

Identification and Validation of a Genetic Risk Signature Associated with Prognosis in Clear-Cell Renal Cell Carcinoma Patients.

Weighted Gene Coexpression Network Analysis to Construct Competitive Endogenous RNA Network in Chromogenic Renal Cell Carcinoma

eRNAs Identify Immune Microenvironment Patterns and Provide a Novel Prognostic Tool in Acute Myeloid Leukemia

A prognostic nomogram based on competing endogenous RNA network for clear-cell renal cell carcinoma

Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma.

Bioinformatic Identification of Key Genes and Analysis of Prognostic Values in Clear Cell Renal Cell Carcinoma.

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma

A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma

Identification of Potential Novel Differentially-Expressed Genes and Their Role in Invasion and Migration in Renal Cell Carcinoma.